4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-046814
Chief Accounting Officer sold 5,000 shares at $32.73 ($163,650)
- Chief Accounting Officer acquired 5,000 shares (option exercise)
- Chief Accounting Officer acquired 722 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2023-09-01 | Option exercise 10b5-1 | +5,000 | $11.35 | $56,750 | 10,132 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-09-01 | Sale 10b5-1 | −5,000 | $32.73 | $163,650 | 5,132 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-09-01 | Grant or award 10b5-1 | +361 | $33.10 | $11,949 | 5,493 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-09-01 | Grant or award 10b5-1 | +361 | 5,854 | D | ||
| Derivatives | |||||||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-09-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 59,167 | D | ||
| Open-market sales · 5,000 sh · avg $32.73 · $163,650 | |||||||
Loading xslF345X05/ownership.xml…